Shorter steroid course may cut relapse in kidney disease patients
NCT ID NCT07151456
First seen Nov 01, 2025 · Last updated May 14, 2026 · Updated 28 times
Summary
This study tests whether a 12-week steroid treatment works as well as the standard 24-week course for adults having their first episode of steroid-sensitive nephrotic syndrome, a kidney condition causing protein leakage and swelling. About 224 participants will be randomly assigned to either the short or long treatment. The main goal is to see if the shorter course reduces the time until the disease comes back.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IDIOPATHIC NEPHROTIC SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Wenzhou Medical University
Wenzhou, Zhejiang, 325000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.